粒细胞集落刺激因子（granulocyte colony stimulating factor，G-CSF）也称为集落刺激因子 3（colony stimulating factor 3，CSF3），是一种含有 174 个 氨基酸的糖蛋白（19.6 ...

This year, it has been joined by natalizumab (Tysabri; Elan/Biogen-Idec), a humanized antibody against α4 integrin, and most recently, the PEGylated humanized anti-TNF-α antibody fragment ...

PP-007 is a unique combination of a carbon monoxide releasing molecule and an oxygen transfer agent. The Food and Drug Administration (FDA) has granted Fast Track designation to PP-007 (PEGylated ...

The transaction includes $70m in cash and a $20m retained equity position for Nektar in a new Ampersand portfolio company.

After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco’s Nektar ...

Nektar Therapeutics (Nasdaq: NKTR), a global biotechnology company focused on the discovery and development of novel therapies to treat autoimmune disorders, today announced that it has entered into a ...

Among patients with polycythemia vera, the treatment pairing of Jakafi and Pegasys shows benefits with acceptable toxicity, ...

Just days after laying out $90 million to acquire Nektar Therapeutics’ Alabama manufacturing plant, Ampersand Capital ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Therapeutics announced that it has entered into a definitive agreement to sell its Huntsville, Alabama manufacturing facility and ...

The transaction, subject to fulfillment of certain customary closing conditions, is expected to be finalized in December, ...